nejm semaglutide heart failure Updates in Medicine | 🩺 Oral Cuts CV Risk in High-Risk T2DM – SOUL Trial (NEJM, Mar 2025) 🔗 Original article link in bio 📌 Key Highlights: 🔹 Semaglutide in Patients with Obesity-Related

For future reconstitutions, switch to bacteriostatic water

Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: a phase 1a, blinded, placebo-controlled, randomized, single- and multiple-ascending-dose study in healthy participants

Semaglutide's appearance varies across its different formulations, each designed for specific therapeutic indications and administration routes

heat shock method involves heat shock to cells at about 42C for about 30 sec to 120 sec and subsequently kept on ice for about 2-10 minutes

What exactly is going on, or that we need to look at: hows your hunger, cravings, and all of that stuff